JEOCAP

This brand name is authorized in Nigeria.

Active ingredients

The drug JEOCAP contains a combination of these active pharmaceutical ingredients (APIs):

1	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol
2	Caffeine UNII 3G6A5W338E - CAFFEINE
	Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.
	Read more about Caffeine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-6284	Tablet	JEOCAP TABLETS TAB 500 mg; 30 mg 10 X 10	159 RNW-PP-160431 JEOCAP TABLETS PARACETAMOL / CAFFINE PARACETAMOL 500MG AND CAFFINE 30MG A4-6284 Drugs Imported Products 10X10 Prescription Only Medicine (POM) 1/21/2021 YELLOW PHARMACEUTICAL COMPANY LIMITED., , EKWULOBIA STREET WOLIWO LAYOUT, ONITSHA ANAMBRA 8090970669 yellowpharmaltd@gmail.com M/S LACTOSE (INDIA) LTD., KHASRA NO.SURVEY NO.6, VILLAGE ,POICHA (RANIA) TALUKA SAVLI, DISTRICT -VADODARA, GUJARAT -391-780, INDIA , India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BE51	Paracetamol, combinations excl. psycholeptics	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-6284